MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Clinical features"

  • 2016 International Congress

    Imaging-based differential diagnosis between multiple system atrophy and Parkinson’s disease

    W. Sako, T. Abe, N. Murakami, Y. Miyazaki, Y. Izumi, M. Harada, R. Kaji (Tokushima, Japan)

    Objective: We aimed to directly compare middle cerebellar peduncle (MCP) width, apparent diffusion coefficient (ADC) value of the putamen and cerebellum, and 123I-metaiodobenzylguanidine (MIBG) myocardial…
  • 2016 International Congress

    Composite autonomic symptom scale-31 (COMPASS-31) is useful for evaluation of autonomic dysfunction in patients with parkinsonism

    Y. Kim, J.M. Seok, H.J. Kim, J. Youn, B.J. Kim, J.W. Cho (Seoul, Korea)

    Objective: To investigate the usefulness of composite autonomic symptom scale 31 (COMPASS-31) in patients with parkinsonism by comparing COMPASS-31 between PD and MSA patients, and…
  • 2016 International Congress

    Disease stage classification of the cerebellar variant of multiple system atrophy based on voxel-based morphometry

    T. Taguchi, K. Nanri, Y. Ueta, H. Terashi, H. Aizawa (Tokyo, Japan)

    Objective: We previously reported that voxel-based morphometry (VBM) is effective for classifying the disease types causing cerebellar atrophy. In the present study, with the objective…
  • 2016 International Congress

    Atypical Parkinsonian disorders: Insights for a differential diagnosis through the analysis of oculomotor profile in MSA, PSP and CBD patients

    F. Rosini, G. Lucii, P. Federighi, E. Pretegiani, F. Giannini, R. Rocchi, A. Federico, A. Rufa (Siena, Italy)

    Objective: To determine peculiar changes in oculomotor profile that may help in distinguishing atypical parkinsonism with overlapping clinical features. Background: Atypical Parkinsonian disorders (APDs) include…
  • 2016 International Congress

    The score changes of clinical symptom assessment scales for multiple system atrophy in 2-3 years

    M. Matsushima, I. Yabe, I. Takahashi, K. Sakushima, F. Nakano, M. Hirotani, T. Kano, K. Horiuchi, H. Houzen, H. Sasaki (Sapporo, Japan)

    Objective: To examine the extent of disease progression for multiple system atrophy (MSA) during relatively long duration. Background: The knowledge of MSA natural history is…
  • 2016 International Congress

    Creative thinking and parkinsonism: Preliminary clinical data on the role of frontal area

    M. Canesi, M. Rusconi, E. Cereda, F. Moroni, A. Ranghetti, V. Cereda, G. Pezzoli (Milano, Italy)

    Objective: To evaluate divergent thinking (DT) by means of Abbreviated Torrance Test for Adults (ATTA) in Parkinsonism (PKS) with different deficit in cognitive functions. Background:…
  • 2016 International Congress

    Early stridor onset predicts survival in multiple system atrophy

    G. Giannini, G. Calandra-Buonaura, F. Mastrolilli, M. Righini, M.L. Bacchi-Reggiani, P. Guaraldi, F. Provini, P. Cortelli (Bologna, Italy)

    Objective: To evaluate the predictive value of stridor and of its latency of onset in a cohort of Multiple System Atrophy (MSA) patients referred to…
  • 2016 International Congress

    Deceleration capacity of heart rate indicates autonomic dysfunction in patients with PSP

    V. Ries, N. Mix, D. Vadasz, A. Bauer, W.H. Oertel (Marburg, Germany)

    Objective: The study focuses on assessing cardiovascular autonomic dysfunction in patients with different atypical Parkinsonian syndromes compared to healthy controls using the heart rate deceleration…
  • 2016 International Congress

    Cerebral vasoreactivity in Parkinson’s disease and multiple system atrophy: A pilot study

    E. Indelicato, F.E. Pontieri, D. Benincasa, A. Fanciulli, F. Orzi, M. Giovannelli, G. Sette (Rome, Italy)

    Objective: To compare cerebral vasoreactivity in Parkinson´s disease (PD) and multiple system atrophy (MSA) patients with or without cardiovascular autonomic failure (CAF). Background: CAF is…
  • 2016 International Congress

    Prevalence and characterisation of vocal fold motion impairment (VFMI) in patients with multiple system atrophy

    M. Renaud, D. Robert, A. Lagier, H. Somma, S. Soulayrol, D. Korchia, F. Fluchère, S. Grimaldi, T. Witjas, J.P. Azulay, A. Eusebio (Marseille, France)

    Objective: Our objective was to describe the characteristics of vocal fold motion impairments (VFMI) in MSA and to determine whether they had a diagnostic and…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley